Structural basis for the transmembrane signaling and antidepressant-induced activation of the receptor tyrosine kinase TrkB.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
29 Oct 2024
Historique:
received: 07 06 2023
accepted: 18 10 2024
medline: 30 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Neurotrophin receptors of the Trk family are involved in the regulation of brain development and neuroplasticity, and therefore can serve as targets for anti-cancer and stroke-recovery drugs, antidepressants, and many others. The structures of Trk protein domains in various states upon activation need to be elucidated to allow rational drug design. However, little is known about the conformations of the transmembrane and juxtamembrane domains of Trk receptors. In the present study, we employ NMR spectroscopy to solve the structure of the TrkB dimeric transmembrane domain in the lipid environment. We verify the structure using mutagenesis and confirm that the conformation corresponds to the active state of the receptor. Subsequent study of TrkB interaction with the antidepressant drug fluoxetine, and the antipsychotic drug chlorpromazine, provides a clear self-consistent model, describing the mechanism by which fluoxetine activates the receptor by binding to its transmembrane domain.

Identifiants

pubmed: 39472452
doi: 10.1038/s41467-024-53710-7
pii: 10.1038/s41467-024-53710-7
doi:

Substances chimiques

Fluoxetine 01K63SUP8D
Receptor, trkB EC 2.7.10.1
Antidepressive Agents 0
tropomyosin-related kinase-B, human EC 2.7.10.1
Membrane Glycoproteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

9316

Subventions

Organisme : Russian Science Foundation (RSF)
ID : 22-14-00130
Organisme : Regional Government of Valencia | Conselleria d'Educació, Investigació, Cultura i Esport (Conselleria d'Educació, Investigació, Cultura i Esport de la Generalitat Valenciana)
ID : INVEST/2022/456
Organisme : Deutsche Forschungsgemeinschaft (German Research Foundation)
ID : CRC 1507

Informations de copyright

© 2024. The Author(s).

Références

Bothwell, M. Recent advances in understanding neurotrophin signaling. F1000Research 5, 1885 (2016).
doi: 10.12688/f1000research.8434.1
Friedman, W. J. & Greene, L. A. Neurotrophin signaling via Trks and p75. Exp. Cell Res. 253, 131–142 (1999).
pubmed: 10579918 doi: 10.1006/excr.1999.4705
Martin-Zanca, D., Hughes, S. H. & Barbacid, M. A human oncogene formed by the fusion of truncated tropomyosin and protein tyrosine kinase sequences. Nature 319, 743–748 (1986).
pubmed: 2869410 doi: 10.1038/319743a0
Cocco, E., Scaltriti, M. & Drilon, A. NTRK fusion-positive cancers and TRK inhibitor therapy. Nat. Rev. Clin. Oncol. 15, 731–747 (2018).
pubmed: 30333516 pmcid: 6419506 doi: 10.1038/s41571-018-0113-0
Segal, R. A. Selectivity in neurotrophin signaling: theme and variations. Annu. Rev. Neurosci. 26, 299–330 (2003).
pubmed: 12598680 doi: 10.1146/annurev.neuro.26.041002.131421
Wehrman, T. et al. Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 53, 25–38 (2007).
pubmed: 17196528 doi: 10.1016/j.neuron.2006.09.034
Wiesmann, C., Ultsch, M. H., Bass, S. H. & De Vos, A. M. Crystal structure of nerve growth factor in complex with the ligand-binding domain of the TrkA receptor. Nature 401, 184–188 (1999).
pubmed: 10490030 doi: 10.1038/43705
Banfield, M. J. et al. Specificity in Trk Receptor:Neurotrophin Interactions. Structure 9, 1191–1199 (2001).
pubmed: 11738045 doi: 10.1016/S0969-2126(01)00681-5
Ultsch, M. H. et al. Crystal structures of the neurotrophin-binding domain of TrkA, TrkB and TrkC 1 1Edited by I. A. Wilson. J. Mol. Biol. 290, 149–159 (1999).
Shoemark, D. K. et al. Design and Nuclear Magnetic Resonance (NMR) Structure Determination Of The Second Extracellular Immunoglobulin Tyrosine Kinase A (TrkAIg2) domain construct for binding site Elucidation in drug discovery. J. Med. Chem. 58, 767–777 (2015).
pubmed: 25454499 doi: 10.1021/jm501307e
Kot, E. F. et al. Intrinsically disordered regions couple the ligand binding and kinase activation of Trk neurotrophin receptors. iScience 25, 104348 (2022).
pubmed: 35601915 pmcid: 9117555 doi: 10.1016/j.isci.2022.104348
Clary, D. O. & Reichardt, L. F. An alternatively spliced form of the nerve growth factor receptor TrkA confers an enhanced response to neurotrophin 3. Proc. Natl Acad. Sci. USA 91, 11133–11137 (1994).
pubmed: 7972023 pmcid: 45181 doi: 10.1073/pnas.91.23.11133
Strohmaier, C., Carter, B. D., Urfer, R., Barde, Y. A. & Dechant, G. A splice variant of the neurotrophin receptor trkB with increased specificity for brain-derived neurotrophic factor. EMBO J. 15, 3332–3337 (1996).
pubmed: 8670834 pmcid: 451896 doi: 10.1002/j.1460-2075.1996.tb00698.x
Urfer, R. et al. High resolution mapping of the binding site of TrkA for nerve growth factor and TrkC for Neurotrophin-3 on the second immunoglobulin-like domain of the Trk Receptors. J. Biol. Chem. 273, 5829–5840 (1998).
pubmed: 9488719 doi: 10.1074/jbc.273.10.5829
Bertrand, T. et al. The crystal structures of TrkA and TrkB suggest key regions for achieving selective inhibition. J. Mol. Biol. 423, 439–453 (2012).
pubmed: 22902478 doi: 10.1016/j.jmb.2012.08.002
Shen, J. & Maruyama, I. N. Brain-derived neurotrophic factor receptor TrkB exists as a preformed dimer in living cells. J. Mol. Signal. 7, 2 (2012).
pubmed: 22269274 pmcid: 3284413 doi: 10.1186/1750-2187-7-2
Shen, J. & Maruyama, I. N. Nerve growth factor receptor TrkA exists as a preformed, yet inactive, dimer in living cells. FEBS Lett. 585, 295–299 (2011).
pubmed: 21187090 doi: 10.1016/j.febslet.2010.12.031
Ahmed, F. & Hristova, K. Dimerization of the Trk receptors in the plasma membrane: effects of their cognate ligands. Biochem. J. 475, 3669–3685 (2018).
pubmed: 30366959 doi: 10.1042/BCJ20180637
Paul, M. D. & Hristova, K. The transition model of RTK activation: a quantitative framework for understanding RTK signaling and RTK modulator activity. Cytokine Growth Factor Rev. 49, 23–31 (2019).
pubmed: 31711797 pmcid: 6898792 doi: 10.1016/j.cytogfr.2019.10.004
Franco, M. L. et al. Structural basis of the transmembrane domain dimerization and rotation in the activation mechanism of the TRKA receptor by nerve growth factor. J. Biol. Chem. 295, 275–286 (2020).
pubmed: 31801826 doi: 10.1074/jbc.RA119.011312
Franco, M. L. et al. Interaction between the transmembrane domains of neurotrophin receptors p75 and TrkA mediates their reciprocal activation. J. Biol. Chem. 297, 100926 (2021).
pubmed: 34216618 pmcid: 8327350 doi: 10.1016/j.jbc.2021.100926
Castrén, E. & Antila, H. Neuronal plasticity and neurotrophic factors in drug responses. Mol. Psychiatry 22, 1085–1095 (2017).
pubmed: 28397840 pmcid: 5510719 doi: 10.1038/mp.2017.61
Casarotto, P. C. et al. Antidepressant drugs act by directly binding to TRKB neurotrophin receptors. Cell 184, 1299–1313.e19 (2021).
pubmed: 33606976 pmcid: 7938888 doi: 10.1016/j.cell.2021.01.034
Moliner, R. et al. Psychedelics promote plasticity by directly binding to BDNF receptor TrkB. Nat. Neurosci. https://doi.org/10.1038/s41593-023-01316-5 (2023).
Bocharov, E. V. et al. Helix-helix interactions in membrane domains of bitopic proteins: Specificity and role of lipid environment. Biochim. Biophys. Acta 1859, 561–576 (2017).
doi: 10.1016/j.bbamem.2016.10.024
Bragin, P. E. et al. HER2 transmembrane domain dimerization coupled with self-association of membrane-embedded cytoplasmic juxtamembrane regions. J. Mol. Biol. 428, 52–61 (2016).
pubmed: 26585403 doi: 10.1016/j.jmb.2015.11.007
Bocharov, E. V. et al. The conformation of the epidermal growth factor receptor transmembrane domain dimer dynamically adapts to the local membrane environment. Biochemistry 56, 1697–1705 (2017).
pubmed: 28291355 doi: 10.1021/acs.biochem.6b01085
Kot, E. F. et al. Oligomerization analysis as a tool to elucidate the mechanism of EBV latent membrane protein 1 inhibition by pentamidine. Biochim. Biophys. Acta BBA - Biomembr. 1862, 183380 (2020).
doi: 10.1016/j.bbamem.2020.183380
Triba, M. N., Warschawski, D. E. & Devaux, P. F. Reinvestigation by phosphorus NMR of lipid distribution in bicelles. Biophys. J. 88, 1887–1901 (2005).
pubmed: 15626702 doi: 10.1529/biophysj.104.055061
Mineev, K. S., Nadezhdin, K. D., Goncharuk, S. A. & Arseniev, A. S. Characterization of small isotropic bicelles with various compositions. Langmuir ACS J. Surf. Colloids 32, 6624–6637 (2016).
doi: 10.1021/acs.langmuir.6b00867
Manni, S. et al. Structural and functional characterization of alternative transmembrane domain conformations in VEGF receptor 2 activation. Structure 22, 1077–1089 (2014).
pubmed: 24980797 doi: 10.1016/j.str.2014.05.010
Bragin, P. E. et al. Probing the effect of membrane contents on transmembrane protein-protein interaction using solution NMR and computer simulations. Biochim. Biophys. Acta Biomembr. 1860, 2486–2498 (2018).
pubmed: 30279150 doi: 10.1016/j.bbamem.2018.09.013
Mineev, K. S. et al. NMR-based approach to measure the free energy of transmembrane helix-helix interactions. Biochim. Biophys. Acta 1838, 164–172 (2014).
pubmed: 24036227 doi: 10.1016/j.bbamem.2013.08.021
Bocharov, E. V. et al. Unique dimeric structure of BNip3 transmembrane domain suggests membrane permeabilization as a cell death trigger. J. Biol. Chem. 282, 16256–16266 (2007).
pubmed: 17412696 doi: 10.1074/jbc.M701745200
Senes, A., Ubarretxena-Belandia, I. & Engelman, D. M. The Calpha -H…O hydrogen bond: a determinant of stability and specificity in transmembrane helix interactions. Proc. Natl Acad. Sci. USA 98, 9056–9061 (2001).
pubmed: 11481472 pmcid: 55372 doi: 10.1073/pnas.161280798
Nicolson, G. L. The Fluid-Mosaic Model of Membrane Structure: still relevant to understanding the structure, function and dynamics of biological membranes after more than 40 years. Biochim. Biophys. Acta 1838, 1451–1466 (2014).
pubmed: 24189436 doi: 10.1016/j.bbamem.2013.10.019
Kornilov, F. D. et al. The architecture of transmembrane and cytoplasmic juxtamembrane regions of Toll-like receptors. Nat. Commun. 14, 1503 (2023).
pubmed: 36932058 pmcid: 10023784 doi: 10.1038/s41467-023-37042-6
Ahmed, F., Paul, M. D. & Hristova, K. The biophysical basis of receptor tyrosine kinase ligand functional selectivity: Trk-B case study. Biochem. J. 477, 4515–4526 (2020).
pubmed: 33094812 doi: 10.1042/BCJ20200671
Lu, C. et al. Structural evidence for loose linkage between ligand binding and kinase activation in the epidermal growth factor receptor. Mol. Cell. Biol. 30, 5432–5443 (2010).
pubmed: 20837704 pmcid: 2976375 doi: 10.1128/MCB.00742-10
Bartzoka, F. et al. Activity of EGFR transmembrane region variants indicates specific transmembrane dimers are not required for EGFR activity. Biochem. J. 479, 2465–2475 (2022).
pubmed: 36416757 doi: 10.1042/BCJ20220472
Testa, G. et al. Disentangling the signaling complexity of nerve growth factor receptors by CRISPR /Cas9. FASEB J. 36, e22498 (2022).
pubmed: 37036720 doi: 10.1096/fj.202101760RR
Cannarozzo, C. et al. Cholesterol‐recognition motifs in the transmembrane domain of the tyrosine kinase receptor family: The case of TRKB. Eur. J. Neurosci. 53, 3311–3322 (2021).
pubmed: 33825223 doi: 10.1111/ejn.15218
Paul, M. D., Rainwater, R., Zuo, Y., Gu, L. & Hristova, K. Probing membrane protein association using concentration‐dependent number and brightness. Angew. Chem. Int. Ed. 60, 6503–6508 (2021).
doi: 10.1002/anie.202010049
Kot, E. F., Goncharuk, S. A., Arseniev, A. S. & Mineev, K. S. Phase transitions in small isotropic Bicelles. Langmuir ACS J. Surf. Colloids 34, 3426–3437 (2018).
Ou, S.-H. I. et al. HER2 Transmembrane Domain (TMD) Mutations (V659/G660) That Stabilize Homo- and Heterodimerization Are Rare Oncogenic Drivers in Lung Adenocarcinoma That Respond to Afatinib. J. Thorac. Oncol. 12, 446–457 (2017).
pubmed: 27903463 doi: 10.1016/j.jtho.2016.11.2224
Sarabipour, S. & Hristova, K. Mechanism of FGF receptor dimerization and activation. Nat. Commun. 7, 10262 (2016).
pubmed: 26725515 pmcid: 4725768 doi: 10.1038/ncomms10262
Russ, W. P. & Engelman, D. M. The GxxxG motif: a framework for transmembrane helix-helix association. J. Mol. Biol. 296, 911–919 (2000).
pubmed: 10677291 doi: 10.1006/jmbi.1999.3489
Nikoletopoulou, V. et al. Neurotrophin receptors TrkA and TrkC cause neuronal death whereas TrkB does not. Nature 467, 59–63 (2010).
pubmed: 20811452 doi: 10.1038/nature09336
Dekkers, M. P. J., Nikoletopoulou, V. & Barde, Y.-A. Death of developing neurons: New insights and implications for connectivity. J. Cell Biol. 203, 385–393 (2013).
pubmed: 24217616 pmcid: 3824005 doi: 10.1083/jcb.201306136
Fantini, J., Di Scala, C., Baier, C. J. & Barrantes, F. J. Molecular mechanisms of protein-cholesterol interactions in plasma membranes: Functional distinction between topological (tilted) and consensus (CARC/CRAC) domains. Chem. Phys. Lipids 199, 52–60 (2016).
pubmed: 26987951 doi: 10.1016/j.chemphyslip.2016.02.009
Suzuki, S. et al. BDNF-induced recruitment of TrkB receptor into neuronal lipid rafts. J. Cell Biol. 167, 1205–1215 (2004).
pubmed: 15596541 pmcid: 2172613 doi: 10.1083/jcb.200404106
Goncharuk, S. A. et al. Bacterial synthesis and purification of normal and mutant forms of human FGFR3 transmembrane segment. Acta Nat. 3, 77–84 (2011).
doi: 10.32607/20758251-2011-3-3-77-84
Motov, V. V. et al. Investigation of lipid/protein interactions in trifluoroethanol-water mixtures proposes the strategy for the refolding of helical transmembrane domains. J. Biomol. NMR 77, 15–24 (2023).
pubmed: 36451032 doi: 10.1007/s10858-022-00408-x
Pervushin, K., Riek, R., Wider, G. & Wüthrich, K. Transverse Relaxation-Optimized Spectroscopy (TROSY) for NMR studies of aromatic spin systems in 13C-Labeled Proteins. J. Am. Chem. Soc. 120, 6394–6400 (1998).
doi: 10.1021/ja980742g
Löhr, F., Hänsel, R., Rogov, V. V. & Dötsch, V. Improved pulse sequences for sequence specific assignment of aromatic proton resonances in proteins. J. Biomol. NMR 37, 205–224 (2007).
pubmed: 17237975 doi: 10.1007/s10858-006-9128-4
Favier, A. & Brutscher, B. Recovering lost magnetization: polarization enhancement in biomolecular NMR. J. Biomol. NMR 49, 9–15 (2011).
pubmed: 21190063 doi: 10.1007/s10858-010-9461-5
Mayzel, M., Kazimierczuk, K. & Orekhov, V. Y. The causality principle in the reconstruction of sparse NMR spectra. Chem. Commun. Camb. Engl. 50, 8947–8950 (2014).
doi: 10.1039/C4CC03047H
Keller, R. R. J. The Computer Aided Resonance Assignment Tutorial. (CANTINA Verlag, 2004).
Güntert, P. & Buchner, L. Combined automated NOE assignment and structure calculation with CYANA. J. Biomol. NMR 62, 453–471 (2015).
pubmed: 25801209 doi: 10.1007/s10858-015-9924-9
Shen, Y. & Bax, A. Protein structural information derived from NMR chemical shift with the neural network program TALOS-N. Methods Mol. Biol. Clifton NJ 1260, 17–32 (2015).
Vuister, G. W., Wang, A. C. & Bax, A. Measurement of three-bond nitrogen-carbon J couplings in proteins uniformly enriched in nitrogen-15 and carbon-13. J. Am. Chem. Soc. 115, 5334–5335 (1993).
doi: 10.1021/ja00065a071
Grzesiek, S., Vuister, G. W. & Bax, A. A simple and sensitive experiment for measurement of JCC couplings between backbone carbonyl and methyl carbons in isotopically enriched proteins. J. Biomol. NMR 3, 487–493 (1993).
pubmed: 8400833 doi: 10.1007/BF00176014
Zwahlen, C. et al. Methods for measurement of intermolecular NOEs by multinuclear NMR spectroscopy: application to a bacteriophage λ N-Peptide/boxB RNA complex. J. Am. Chem. Soc. 119, 6711–6721 (1997).
doi: 10.1021/ja970224q
Zheng, G. & Price, W. S. Simultaneous convection compensation and solvent suppression in biomolecular NMR diffusion experiments. J. Biomol. NMR 45, 295–299 (2009).
pubmed: 19697137 doi: 10.1007/s10858-009-9367-2
Kot, E. F., Arseniev, A. S. & Mineev, K. S. Behavior of most widely spread lipids in isotropic bicelles. Langmuir 34, 8302–8313 (2018).
pubmed: 29924628 doi: 10.1021/acs.langmuir.8b01454
Chill, J. H., Louis, J. M., Baber, J. L. & Bax, A. Measurement of 15N relaxation in the detergent-solubilized tetrameric KcsA potassium channel. J. Biomol. NMR 36, 123–136 (2006).
pubmed: 17013683 doi: 10.1007/s10858-006-9071-4
Koradi, R., Billeter, M. & Wüthrich, K. MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51–55 (1996).
pubmed: 8744573 doi: 10.1016/0263-7855(96)00009-4
Kučerka, N., Nieh, M.-P. & Katsaras, J. Fluid phase lipid areas and bilayer thicknesses of commonly used phosphatidylcholines as a function of temperature. Biochim. Biophys. Acta 1808, 2761–2771 (2011).
pubmed: 21819968 doi: 10.1016/j.bbamem.2011.07.022
Jóhannesson, H. & Halle, B. Solvent diffusion in ordered macrofluids: a stochastic simulation study of the obstruction effect. J. Chem. Phys. 104, 6807 (1996).
doi: 10.1063/1.471347
Keller, P., Toomre, D., Díaz, E., White, J. & Simons, K. Multicolour imaging of post-Golgi sorting and trafficking in live cells. Nat. Cell Biol. 3, 140–149 (2001).
pubmed: 11175746 doi: 10.1038/35055042
Wimley, W. C. & White, S. H. Experimentally determined hydrophobicity scale for proteins at membrane interfaces. Nat. Struct. Biol. 3, 842–848 (1996).
pubmed: 8836100 doi: 10.1038/nsb1096-842

Auteurs

Erik F Kot (EF)

Faculty of Biology, Shenzhen MSU-BIT University, Shenzhen, China.
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Sergey A Goncharuk (SA)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

María Luisa Franco (ML)

Instituto de Biomedicina de Valencia-CSIC, València, Spain.
Valencia Biomedical Research Foundation, Centro de Investigación Príncipe Felipe (CIPF) - Associated Unit to the IBV-CSIC, 3, Valencia, Spain.

Daniel M McKenzie (DM)

Department of Materials Science and Engineering and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA.

Alexander S Arseniev (AS)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia.

Andrea Benito-Martínez (A)

Instituto de Biomedicina de Valencia-CSIC, València, Spain.
Valencia Biomedical Research Foundation, Centro de Investigación Príncipe Felipe (CIPF) - Associated Unit to the IBV-CSIC, 3, Valencia, Spain.

Mario Costa (M)

Scuola Normale Superiore Laboratory of Biology BIO@SNS, Pisa, Italy.
CNR Neuroscience Institute, Pisa, Italy.

Antonino Cattaneo (A)

Scuola Normale Superiore Laboratory of Biology BIO@SNS, Pisa, Italy.

Kalina Hristova (K)

Department of Materials Science and Engineering and Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD, USA.

Marçal Vilar (M)

Instituto de Biomedicina de Valencia-CSIC, València, Spain. mvilar@ibv.csic.es.
Valencia Biomedical Research Foundation, Centro de Investigación Príncipe Felipe (CIPF) - Associated Unit to the IBV-CSIC, 3, Valencia, Spain. mvilar@ibv.csic.es.

Konstantin S Mineev (KS)

Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Moscow, Russia. konstantin.mineev@gmail.com.
Goethe University Frankfurt, Frankfurt am Main, Germany, Germany. konstantin.mineev@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH